Expression and significance of hypoxia-inducible factor‑1α and glucose transporter-1 in laryngeal carcinoma Corrigendum in /ol/6/1/287

Wu,Xiao-Hong; Chen,Su-Ping; Mao,Jian-Ying; Ji,Xue‑Xian; Yao,Hong-Tian; Zhou,Shui-Hong

doi:10.3892/ol.2012.941

January 2013 Volume 5 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January 2013 Volume 5 Issue 1

Full Size Image

Article

Expression and significance of hypoxia-inducible factor‑1α and glucose transporter-1 in laryngeal carcinoma

Corrigendum in: /ol/6/1/287

Authors:
- Xiao-Hong Wu
- Su-Ping Chen
- Jian-Ying Mao
- Xue‑Xian Ji
- Hong-Tian Yao
- Shui-Hong Zhou
View Affiliations / Copyright

Affiliations: Department of Otolaryngology, The People's Hospital of Deqing County, Zhejiang (The Cooperative Hospital of The First Affiliated Hospital, College of Medicine, Zhejiang University), Deqing City, P.R. China, Department of Otolaryngology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China, Department of Pathology, The People’s Hospital of Deqing County, Zhejiang (The Cooperative Hospital of The First Affiliated Hospital, College of Medicine, Zhejiang University), Deqing City, P.R. China
Pages: 261-266
|
Published online on: September 26, 2012

https://doi.org/10.3892/ol.2012.941
Expand metrics +

Abstract

Malignant cells show increased glucose uptake in vitro and in vivo. This process is considered to be mediated by glucose transporters (GLUTs). Hypoxia-inducible factor-1α (HIF-1α) may upregulate GLUT-1 expression. Little is known about the correlation between HIF-1α and GLUT-1 expression in laryngeal carcinoma. The current study investigated this correlation immunohistochemically, according to various clinical and pathological features, in 49 paraffin‑embedded archival tissue blocks from patients with laryngeal squamous cell carcinoma. HIF-1α and GLUT-1 expression was detected in 63.3 (31/49) and 55.1% (27/49) of the tumour samples, respectively. HIF-1α expression was significantly correlated with lymph node classification (P=0.018), recurrence (P=0.02) and metastasis (P=0.031). GLUT-1A expression was significantly associated with recurrence (P=0.02) and metastasis (P=0.01). Univariate analyses revealed that HIF-1α (χ2=8.2; P=0.004) and GLUT-1 expression (χ2=9.0; P=0.003) were significantly associated with a poorer survival rate. In a multivariate analysis, GLUT-1 expression (P=0.006) was a significant predictor of poor survival rate, as well as the primary tumour site, lymph node invasion and distant metastasis. Based on Spearman's analysis, GLUT-1 expression and phosphatidylinositol 3-kinase (PI3K) expression were significantly correlated (r=0.504; P=0.000). This is the first study to demonstrate a significant correlation between GLUT-1 and HIF-1α expression in laryngeal carcinoma and to show increased GLUT-1 expression as an independent survival rate predictor. These results suggest that GLUT-1 is a potential new therapeutic target for laryngeal carcinoma.

View Figures

View References

1	Yasuda M, Miyazawa M, Fujita M, et al: Expression of hypoxia inducible factor-1α (HIF-1α) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep. 19:111–116. 2008.
2	Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL and Jakobsen A: Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res. 31:1559–1565. 2011.
3	Gu J, Yamamoto H, Fukunaga H, et al: Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci. 51:198–205. 2006.PubMed/NCBI
4	Merrall NW, Plevin R and Gould GW: Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal. 5:667–675. 1993. View Article : Google Scholar : PubMed/NCBI
5	Zhou S, Wang S, Wu Q, Fan J and Wang Q: Expression of glucose transporter-1 and -3 in the head and neck carcinoma - the correlation of the expression with the biological behaviors. ORL J Otorhinolaryngol Relat Spec. 70:189–194. 2008. View Article : Google Scholar : PubMed/NCBI
6	Eckert AW, Lautner MH, Taubert H, Schubert J and Bilkenroth U: Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients. Oncol Rep. 20:1381–1385. 2008.PubMed/NCBI
7	Deron P, Vermeersch H, Mees G, Vangestel C, Pauwels P and Van de Wiele C: Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma. Histol Histopathol. 26:1165–1172. 2011.PubMed/NCBI
8	Nakajo M, Nakajo M, Tani A, et al: Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas. Eur Radiol. 21:2396–2407. 2011. View Article : Google Scholar
9	Kondo Y, Yoshikawa K, Omura Y, et al: Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma. Oncol Rep. 25:1227–1233. 2011.PubMed/NCBI
10	Deron P, Vangestel C, Goethals I, et al: FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin. 50:15–21. 2011. View Article : Google Scholar : PubMed/NCBI
11	Ayala FR, Rocha RM, Carvalho KC, et al: GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma. Molecules. 15:2374–2387. 2010. View Article : Google Scholar : PubMed/NCBI
12	Pez F, Dayan F, Durivault J, et al: The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 71:1647–1657. 2011. View Article : Google Scholar : PubMed/NCBI
13	Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J and Bilkenroth U: Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology. 58:1136–1147. 2011.
14	Ogane N, Yasuda M, Shimizu M, et al: Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma. Ann Diagn Pathol. 14:23–29. 2010. View Article : Google Scholar : PubMed/NCBI
15	Sulkowska M, Wincewicz A, Sulkowski S, Koda M and Kanczuga-Koda L: Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology. 41:254–260. 2009. View Article : Google Scholar : PubMed/NCBI
16	Iida T, Yasuda M, Miyazawa M, et al: Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1α/GLUT-1 expression. Arch Gynecol Obstet. 277:539–546. 2008.PubMed/NCBI
17	Lidgren A, Bergh A, Grankvist K, Rasmuson T and Ljungberg B: Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int. 101:480–484. 2008.PubMed/NCBI
18	Palit V, Phillips RM, Puri R, Shah T and Bibby MC: Expression of HIF-1α and Glut-1 in human bladder cancer. Oncol Rep. 14:909–913. 2005.
19	Koukourakis MI, Giatromanolaki A, Harris AL and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 66:632–637. 2006. View Article : Google Scholar
20	Wincewicz A, Sulkowska M, Koda M and Sulkowski S: Clinicopathological significance and linkage of the distribution of HIF-1α and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res. 13:15–20. 2007.PubMed/NCBI
21	Schrijvers ML, van der Laan BF, de Bock GH, et al: Overexpression of intrinsic hypoxia markers HIF1α and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 72:161–169. 2008.PubMed/NCBI
22	Wu XH, Lu YF, Hu XD, et al: Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma. J Int Med Res. 38:2040–2046. 2010.
23	Yu L, Liu Y and Cui Y: Expression of hypoxia inducible factor-1alpha and its relationship to apoptosis and proliferation in human laryngeal squamous cell carcinoma. J Huazhong Univ Sci Technolog Med Sci. 24:636–638. 2004. View Article : Google Scholar : PubMed/NCBI
24	Luo XM, Zhou SH and Fan J: Glucose transporter-1 as a new therapeutic target in laryngeal carcinoma. J Int Med Res. 38:1885–1892. 2010. View Article : Google Scholar : PubMed/NCBI
25	Zhou SH, Fan J, Chen XM, Cheng KJ and Wang SQ: Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck. 31:1624–1633. 2009. View Article : Google Scholar : PubMed/NCBI
26	Weljie AM and Jirik FR: Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Int J Biochem Cell Biol. 43:981–989. 2011. View Article : Google Scholar : PubMed/NCBI
27	Wan J, Chai H, Yu Z, et al: HIF-1α effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res. 30:772011.
28	Cabanillas R, Rodrigo JP, Secades P, et al: The relation between hypoxia-inducible factor (HIF)-1α expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer. J Surg Oncol. 99:373–378. 2009.
29	Wildeman MA, Gibcus JH, Hauptmann M, et al: Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response? Laryngoscope. 119:316–322. 2009. View Article : Google Scholar : PubMed/NCBI